Along with daily surveys, a research team from Mount Sinai used Apple Watches to measure how stress impacted healthcare workers' bodies and pinpointed the characteristics that were associated with lower stress levels over time.
According to a report by the Wall Street Journal, Apple is planning to add more health features to its watch, including a feature to track blood pressure and a wrist-based thermometer.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
BioIntelliSense, a startup with backers including UCHealth and Royal Philips, recently raised $45 million. The company began marketing its sticker-like device to monitor patients’ vitals last year after getting FDA clearance at the end of 2019.
Read about new developments from HealthMine, TailorMed, Heru and Entos.
Google recently reshuffled its health division, moving a significant number of employees over to its Fitbit and Search businesses. Analysts said it's no surprise Google would focus its consumer health efforts on Fitbit, given Fitbit’s broad reach and the competition to add more meaningful health features to these devices.
The next step in the evolution of interoperability will involve examining data flows in digital healthcare, according to panelists at the American Telemedicine Association's annual conference. This includes looking into how data sharing will support telehealth, remote patient monitoring and programs involving wearables.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
Oura, a startup making a sleep tracker in the form of a ring, raised $100 million in funding. The startup plans to more develop features that would help people better understand what to do with their health data.
The science of using sensor data to define, measure, and create mathematical models of disease can lead to better outcomes—and huge benefits—for everyone in healthcare and life sciences.
Fitbit is launching a trial to see if its its newest smartwatch could use pulse arrival time to measure blood pressure. Other wearable companies have tried to add wrist-based blood pressure features to their devices, but so far, they have limited accuracy.
Google announced it had closed its planned acquisition of Fitbit on Thursday, even thought the deal is still being investigated by the U.S. Department of Justice.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
In this webinar on Feb. 10, healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than holter monitors, represent a new standard of care in remote cardiac monitoring.
After European regulators signed off on the deal, Australian regulators rejected a proposal by Google to assuage concerns about its proposed acquisition of Fitbit. They will continue their investigation of the merger through the end of March.
Remote monitoring startup BioIntelliSense and Royal Phillips received $2.8 million to test BioIntelliSense’s device for the early detection of Covid-19 symptoms. The startup received FDA clearance for its small, adhesive monitoring device last year.
The virtual study, which included wearable data from more than 30,500 participants, found that changes in sleep, activity and heart rate levels, along with self-reported symptom data, could be used to identify potential cases of Covid-19.
After sharing early data from a study of its wearables’ ability to detect Covid-19 early, Fitbit plans to launch a prospective study with Northwell Health to see if its algorithm can detect illness before symptoms appear.